Young adult leukemia, lymphoma survivors more distressed than older survivors
the ONA take:
According to two new studies published in the Journal of Psychosocial Oncology, researchers from University of Colorado Cancer Center in Denver, Colorado, have found that young adult survivors of leukemia and lymphoma are more likely to report high stress compared with older survivors of the same diseases.
Specifically, researchers found that 45% of patients aged 18-39 years old reported moderate-to-high distress, while 18% of those over 65 years reported the same level of distress. Neither group's distress was affected by time since cancer treatment.
The first study surveyed 477 cancer survivors. Researchers found that survivors under age 40 had the highest prevalence of distress, mostly due patients' fear of cancer recurrence. Survivors were also concerned with the high financial burden.
The second study interviewed 51 survivors of leukemia to better understand their reasons for high distress. Some patients were concerned about the financial burden, while others stressed about how long it would take to fully recover both physically and mentally.
The findings reinforce the importance of identifying those who are most likely to experience elevated stress levels and to understand their reasons for concern so that targeted interventions can be implemented.
Young adult survivors of leukemia and lymphoma are more likely to report high stress compared with older survivors of the same diseases.
Sign Up for Free e-newsletters
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Intensive Chemotherapy May Not Be Effective in MDS or AML After MDS
- ASCO Endorses SIO Guideline for Integrative Therapies in Breast Cancer
- Seeking Reliable Information on Herbal Products
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Adhering to Cytoreductive Therapy Use May Improve Outcomes in Polycythemia Vera
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|